Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
了解更多
Webinar: Multiplex Serological Assay Developed to Identify Avian Influenza Subtypes
Rapid detection could help prevent transmission and reduce flock losses
In this 20-minute video presentation, veterinarian Evelien Germeraad reports on the development and validation of that assay. Wageningen Bioveterinary Research, part of Wageningen University & Research, is a national reference lab for infectious animal diseases, receiving samples for testing from all over the country. The lab tests cattle, poultry, goats, and other types of animals for illnesses ranging from rabies and tularemia to psittacosis and foot-and-mouth disease.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
February 18th
Luminex Corporation Declares First Quarter Cash Dividend
February 13th
Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020
February 10th
Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results
AACR Annual Meeting
April 24-29
San Diego, CA
Clinical Virology Symposium (CVS)
May 3-6
West Palm Beach, FL
Immunology
May 8-12
Honolulu, HI
